Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation

Vaccine

Volumn 25, Issue 32, 2007, Pages 5994-6006

  Liang, Rong ^a   Babiuk, Lorne A ^a   Hurk, Sylvia van Drunen Littel van den ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bovine viral diarrhea virus; Combination; DNA vaccine; Type 1 E2; Type 2 E2

Indexed keywords

DNA VACCINE; PLASMID DNA; VIRUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE DIARRHEA VIRUS; CARBOXY TERMINAL SEQUENCE; CATTLE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG FORMULATION; EXCIPIENT COMPATIBILITY; IMMUNE RESPONSE; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNITED STATES; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CELL LINE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; PLASMIDS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 34447559505     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.036     Document Type: Article

References (34)

1. Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol 64 2-3 (1999) 89-107
2. van Drunen Littel-van den Hurk S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R., et al. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv Drug Deliv Rev 43 1 (2000) 13-28
3. Kong W.P., Huang Y., Yang Z.Y., Chakrabarti B.K., Moodie Z., and Nabel G.J. Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines. J Virol 77 23 (2003) 12764-12772
4. Konishi E., Kosugi S., and Imoto J. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine 24 12 (2006) 2200-2207
5. Kwissa M., Unsinger J., Schirmbeck R., Hauser H., and Reimann J. Polyvalent DNA vaccines with bidirectional promoters. J Mol Med 78 9 (2000) 495-506
6. Kojima Y., Jounai N., Takeshita F., Nakazawa M., Okuda K., Watabe S., et al. The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection. Vaccine 25 3 (2007) 438-445
7. Manoj S., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses. Virology 313 1 (2003) 296-307
8. Mizuguchi H., Xu Z., Ishii-Watabe A., Uchida E., and Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1 4 (2000) 376-382
9. Mountford P.S., and Smith A.G. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 11 5 (1995) 179-184
10. Shkreta L., Talbot B.G., Diarra M.S., and Lacasse P. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23 1 (2004) 114-126
11. Wild J., Gruner B., Metzger K., Kuhrober A., Pudollek H.P., Hauser H., et al. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 16 4 (1998) 353-360
12. Harpin S., Hurley D.J., Mbikay M., Talbot B., and Elazhary Y. Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J Gen Virol 80 Pt 12 (1999) 3137-3144
13. Liang R., van den Hurk J.V., Babiuk L.A., and van Drunen Littel-van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. J Gen Virol 87 Pt 10 (2006) 2971-2982
14. Liang R., van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., et al. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine 23 45 (2005) 5252-5262
15. Nobiron I., Thompson I., Brownlie J., and Collins M.E. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 21 17-18 (2003) 2082-2092
16. Young N.J., Thomas C.J., Thompson I., Collins M.E., and Brownlie J. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle. Prev Vet Med 72 1-2 (2005) 115-120 [discussion 215-9]
17. Jang S.K., Krausslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., and Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62 8 (1988) 2636-2643
18. Pelletier J., and Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334 6180 (1988) 320-325
19. Brown E.A., Day S.P., Jansen R.W., and Lemon S.M. The 5′ nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol 65 11 (1991) 5828-5838
20. Tsukiyama-Kohara K., Iizuka N., Kohara M., and Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 66 3 (1992) 1476-1483
21. Kuhn R., Luz N., and Beck E. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J Virol 64 10 (1990) 4625-4631
22. Bandbon Balenga N.A., Thalhamer J., and Weiss R. Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention. Med Hypotheses 67 1 (2006) 71-74
23. Baca-Estrada M.E., Snider M., Tikoo S.K., Harland R., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol 9 1 (1996) 11-22
24. Raggo C., Habermehl M., Babiuk L.A., and Griebel P. The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. J Gen Virol 81 Pt 11 (2000) 2665-2673
25. Braun R.P., Babiuk L.A., and van Drunen Littel-van den Hurk S. Enhanced immune responses to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD. Vacc Res 6 (1997) 151-164
26. Lewis P.J., van Drunen Littel-van den H., and Babiuk L.A. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 73 12 (1999) 10214-10223
27. van Drunen Littel-van den H., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., et al. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 79 Pt 4 (1998) 831-839
28. Corapi W.V., French T.W., and Dubovi E.J. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J Virol 63 9 (1989) 3934-3943
29. Bolin S.R., and Ridpath J.F. Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest 10 2 (1998) 135-139
30. Fulton R.W., Ridpath J.F., Confer A.W., Saliki J.T., Burge L.J., and Payton M.E. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 31 2 (2003) 89-95
31. Ridpath J.F. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs. Prev Vet Med 72 1-2 (2005) 17-30 [discussion 215-9]
32. Braun R., Babiuk L.A., and van Drunen Littel-van den H. Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation. J Gen Virol 79 Pt 12 (1998) 2965-2970
33. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., and Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. J Virol 72 3 (1998) 2516-2518
34. Sedegah M., Charoenvit Y., Minh L., Belmonte M., Majam V.F., Abot S., et al. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther 11 5 (2004) 448-456